Lataa...
Recent advances in the understanding and treatment of acute myeloid leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease that has a poor prognosis. Recent advances in genomics and molecular biology have led to a greatly improved understanding of the disease. Until 2017, there had been no new drugs approved for AML in decades. Here, we r...
Tallennettuna:
| Julkaisussa: | F1000Res |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
F1000 Research Limited
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081972/ https://ncbi.nlm.nih.gov/pubmed/30135719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.14116.1 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|